Cargando…
Test Performance and Potential Clinical Utility of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel
The test performance and potential clinical utility of the ePlex blood culture identification Gram-negative (BCID-GN) panel was evaluated relative to matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) mass spectrometry on bacterial isolates and conventional antimicrobial suscepti...
Autores principales: | McCarty, T. P., Cumagun, P., Meeder, J., Moates, D., Edwards, W. S., Hutchinson, J., Lee, R. A., Leal, S. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927486/ https://www.ncbi.nlm.nih.gov/pubmed/36688641 http://dx.doi.org/10.1128/spectrum.04092-22 |
Ejemplares similares
-
214. Prospective Evaluation of the GenMark Dx ePlex(®) Blood Culture Identification Gram Negative Panel
por: Meeder, Jeremy, et al.
Publicado: (2021) -
200. Prospective Evaluation of the GenMark Dx ePlex(®) Blood Culture Identification Gram Positive Panel
por: Meeder, Jeremy, et al.
Publicado: (2021) -
1022. Evaluating the Impact of GenMark Dx ePlex® Blood Culture Identification (BCID) on Gram-negative Bloodstream Infections
por: Cumagun, Pia, et al.
Publicado: (2021) -
359. The Clinical Utility of the GenMark Dx ePlex® Fungal Blood Culture Identification Panel
por: Carmona, Stefania, et al.
Publicado: (2022) -
The impact of GenMark Dx ePlex blood-culture identification on the treatment and outcomes of gram-positive bacteremia
por: Kiszla, B. Matthew, et al.
Publicado: (2022)